Independent Expert

Sarah Lukie

Managing Director, Regulatory and Multilateral Affairs, Plant Biotechnology at CropLife International

Sarah Lukie currently serves as the Managing Director for Regulatory and Multilateral Affairs, Plant Biotechnology, based at CropLife International (CLI) in Washington, DC.   In this role, Sarah works on the development of CLI’s positions and activities on regulatory and multilateral policy issues impacting the global agricultural biotechnology sector.  She has particular expertise representing the biotechnology industry in negotiation and implementation of various multilateral environmental agreements, such as the Cartagena Protocol on Biotechnology, the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress, the Convention on Biological Diversity and the Codex Alimentarius.  Sarah leads a global effort to coordinate policy positions on a number of multilateral environmental agreements among the agricultural biotechnology industry, serving as the Secretariat to the Global Industry Coalition, a coalition of stakeholders participating in the implementation of the Cartagena Protocol on Biosafety, as well as the Global Adventitious Presence Coalition, an international coalition of the “food chain” stakeholders working towards solutions to issues related to asynchronous approvals of agricultural biotechnology products around the world.  Additionally, Sarah serves as the Executive Director of the Compact, a legally binding arbitration process to provide States with a mechanism for seeking redress in the event that damage to biological diversity is caused by the release of a Living Modified Organism.

Sarah is a lawyer who has focused her legal work on assisting developing countries draft and implement their national biosafety frameworks in order to comply with the requirements of the Cartagena Protocol on Biosafety.  As such, she has significant experience drafting biosafety policies, laws and regulations at the national level.  She also serves on a number of UN Liaison Groups and Committees, working to build the capacity of developing countries to regulate products of agricultural biotechnology with a science-based, predictable and transparent regulatory system.

Sarah is a Canadian who received her First Class Honors Bachelor Degree from Simon Fraser University in British Columbia. She also studied international environmental law and obtained her law degree from the University of British Columbia, located in Vancouver, Canada.

From this Expert

Posted On: Monday, 8/05/2013 10:48 am
A: Within the context of biotech crops, adventitious presence or AP occurs when trace amounts of an agricultural biotech product that has not been approved for commercial use (e.g., research events, field trial escapes) by any competent government authority, but is found in the commercial crop or food supply despite best agricultural and manufacturing practices.  In the context of agricultural biotechnology, a similar concept of low level presence or LLP is defined as the unintentional, low... Continue Reading
No Studies were Found.